Codex DNA Inc.

NASDAQ: DNAY · Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM

Codex DNA Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-48.47M -38.96M
Depreciation & Amortization
1.67M 908K
Stock-Based Compensation
3.73M 1.09M
Other Working Capital
855K -5.23M
Other Non-Cash Items
5.21M 3.3M
Deferred Income Tax
n/a n/a
Change in Working Capital
-855K -3.04M
Operating Cash Flow
-38.72M -36.7M
Capital Expenditures
-4.47M -1.85M
Cash Acquisitions
n/a n/a
Purchase of Investments
-77.43M n/a
Sales Maturities Of Investments
64.44M n/a
Other Investing Acitivies
-556K -13.19M
Investing Cash Flow
-18.01M -15.04M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
4.51M 121.08M
Financial Cash Flow
4.51M 121.08M
Net Cash Flow
-52.21M 69.34M
Free Cash Flow
-43.18M -38.55M